ERBB2 and cancer: Triple negative breast cancer (TNBC) is defined by estrogen and progesterone receptor staining less than 1% of cancer cells and HER2 testing that is negative for protein expression or gene amplification (IHC 0 or 1+, or IHC 2+ and ISH negative) [29].